Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$780M |
| 2 |
Uber
UBER
|
+$708M |
| 3 |
Goldman Sachs
GS
|
+$569M |
| 4 |
Microsoft
MSFT
|
+$430M |
| 5 |
Netflix
NFLX
|
+$415M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$973M |
| 2 |
Intuitive Surgical
ISRG
|
+$872M |
| 3 |
Nike
NKE
|
+$844M |
| 4 |
Edwards Lifesciences
EW
|
+$805M |
| 5 |
Corpay
CPAY
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.66% |
| 2 | Consumer Discretionary | 19.04% |
| 3 | Healthcare | 13.04% |
| 4 | Communication Services | 12.22% |
| 5 | Financials | 10.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
T-Mobile US
TMUS
$190B
| $1.64M | ﹤0.01% |
+19,554
| New | +$1.65M |
|
452
Ziff Davis
ZD
$1.98B
| $1.63M | ﹤0.01% |
+24,978
| New | +$1.95M |
|
453
iShares MSCI ACWI ETF
ACWI
$33.5B
| $1.62M | ﹤0.01% |
25,868
+4,618
| +22% | +$342K |
|
454
Gilead Sciences
GILD
$165B
| $1.61M | ﹤0.01% |
+21,587
| New | +$1.49M |
|
455
McKesson
MCK
$101B
| $1.57M | ﹤0.01% |
+11,614
| New | +$1.7M |
|
456
HCA Healthcare
HCA
$89.5B
| $1.57M | ﹤0.01% |
+17,466
| New | +$2.26M |
|
|
AMTD
457
DELISTED
TD Ameritrade Holding Corp
AMTD
| $1.55M | ﹤0.01% |
44,785
-452,678
| -91% | -$19.7M |
|
|
DHR.PRA
458
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
| $1.55M | ﹤0.01% |
1,497
-16
| -1% | -$18.4K |
|
459
Hershey
HSY
$36.6B
| $1.52M | ﹤0.01% |
11,469
+2,621
| +30% | +$387K |
|
460
Deere & Co
DE
$168B
| $1.51M | ﹤0.01% |
+10,949
| New | +$1.73M |
|
461
Employers Holdings
EIG
$889M
| $1.47M | ﹤0.01% |
+36,238
| New | +$1.48M |
|
|
ARNA
462
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.43M | ﹤0.01% |
33,995
+14,965
| +79% | +$686K |
|
|
MLNX
463
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $1.43M | ﹤0.01% |
+11,769
| New | +$1.38M |
|
464
HP
HPQ
$27.5B
| $1.4M | ﹤0.01% |
+80,507
| New | +$1.63M |
|
465
Honeywell
HON
$78B
| $1.34M | ﹤0.01% |
10,659
+7,961
| +295% | +$1.23M |
|
|
AMED
466
DELISTED
Amedisys
AMED
| $1.34M | ﹤0.01% |
7,316
+174
| +2% | +$31K |
|
467
NN Inc
NNBR
$291M
| $1.31M | ﹤0.01% |
755,979
-962,601
| -56% | -$6.89M |
|
|
SF
468
Stifel
SF
$12.6B
| $1.25M | ﹤0.01% |
67,891
+10,278
| +18% | +$257K |
|
469
Ameriprise Financial
AMP
$48.8B
| $1.24M | ﹤0.01% |
12,124
+638
| +6% | +$94.5K |
|
470
Petrobras
PBR
$116B
| $1.23M | ﹤0.01% |
223,416
-84
| -0% | -$1K |
|
471
Methode Electronics
MEI
$592M
| $1.22M | ﹤0.01% |
46,212
+8,755
| +23% | +$285K |
|
472
Dell
DELL
$293B
| $1.21M | ﹤0.01% |
+60,480
| New | +$1.4M |
|
|
EQM
473
DELISTED
EQM Midstream Partners, LP
EQM
| $1.19M | ﹤0.01% |
100,416
-10,821
| -10% | -$220K |
|
474
International Bancshares
IBOC
$4.57B
| $1.18M | ﹤0.01% |
43,792
-1,508
| -3% | -$54K |
|
475
Maximus
MMS
$3.11B
| $1.17M | ﹤0.01% |
20,076
-335
| -2% | -$22.7K |
|
Similar funds
Jennison Associates's Q1 2020 Portfolio in Review
As of Q1 2020, Jennison Associates held 749 positions worth $82.3B, down 17% from $99.1B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Jennison Associates withdrew a net $4.86B in Q1 2020, closing 131 positions and reducing 247 holdings. Its most notable exit was Parker-Hannifin, an estimated $116M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Atlassian worth $350M.
- Jennison Associates's largest Q1 2020 buy was Atlassian: 2,552,272 shares worth $350M.
- Jennison Associates added most to Eli Lilly in Q1 2020, an estimated $780M increase.
- Jennison Associates's biggest Q1 2020 reduction was Walt Disney, cutting an estimated $973M.
- Jennison Associates fully exited Parker-Hannifin in Q1 2020, selling an estimated $116M.
- Jennison Associates's ten largest holdings make up 40% of its $82.3B portfolio in Q1 2020.
- Jennison Associates opened 131 new positions and closed 131 in Q1 2020.
- Jennison Associates's portfolio value fell 17% quarter-over-quarter to $82.3B.
Based on Jennison Associates's 13F filing for Q1 2020, filed 6 May 2020.